12 Health Care Stocks Moving In Wednesday's After-Market Session

Gainers

  • Bellerophon Therapeutics BLPH shares increased by 18.4% to $2.9 during Wednesday's after-market session. This security traded at a volume of 416.2K shares come close, making up 40.3% of its average volume over the last 100 days. The company's market cap stands at $27.6 million.
  • NanoVibronix NAOV shares rose 12.32% to $0.36. The market value of their outstanding shares is at $11.8 million.
  • Nymox Pharmaceutical NYMX shares moved upwards by 10.34% to $0.53. The market value of their outstanding shares is at $47.9 million.
  • Infinity Pharmaceuticals INFI shares increased by 7.69% to $0.75. The market value of their outstanding shares is at $66.6 million.
  • Kiromic BioPharma KRBP shares rose 7.31% to $0.22. The market value of their outstanding shares is at $4.0 million.
  • Tivic Health Systems TIVC shares rose 7.0% to $0.77. The company's market cap stands at $7.4 million.

Losers

  • Lyell Immunopharma LYEL stock decreased by 6.1% to $2.81 during Wednesday's after-market session. The market value of their outstanding shares is at $699.7 million.
  • Ontrak OTRKP stock fell 6.11% to $1.23. Today's trading volume for this security ended up closing at 51.0K shares, which is 282.2 percent of its average volume over the last 100 days.
  • Biofrontera BFRI stock decreased by 5.26% to $0.9. The company's market cap stands at $24.0 million.
  • Seelos Therapeutics SEEL stock declined by 5.0% to $0.93. The company's market cap stands at $99.7 million.
  • Concert Pharma CNCE shares declined by 4.93% to $6.56. The market value of their outstanding shares is at $314.4 million.
  • Zynerba Pharmaceuticals ZYNE stock decreased by 4.92% to $0.58. The market value of their outstanding shares is at $27.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!